← Back to Search

Behavioral Intervention

Mindfulness + Pain Management Visits for Chronic Pain

N/A

Waitlist Available

Research Sponsored by University of Utah

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Current use of opioids for ≥3 months

Age 18 +

Must not have

Chronic pain due to a cancer diagnosis

Timeline

Screening 3 weeks

Treatment Varies

Follow Up change from baseline through study completion (assessed at 3-, 6-, 9-, and 12-months follow-up)

Awards & highlights

No Placebo-Only Group

Summary

"This trial aims to see if using Mindfulness-Oriented Recovery Enhancement (MORE) and patient-centered chronic pain management visits can help reduce chronic pain, improve quality of life, and lessen the negative effects

Who is the study for?

This trial is for individuals with chronic pain who are currently on long-term opioid therapy. It's aimed at those experiencing substance use disorders, neurologic symptoms, or mental illness related to narcotic use. Specific eligibility criteria were not provided.

What is being tested?

The study tests the effectiveness of Mindfulness-Oriented Recovery Enhancement (MORE) and patient-centered chronic pain management visits in primary care settings to alleviate chronic pain, enhance life quality, and minimize opioid misuse.

What are the potential side effects?

Since this trial involves mindfulness practices and patient-centered visits rather than medication, typical drug side effects aren't expected. However, participants may experience emotional discomfort or distress during the process.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have been using opioids for 3 months or more.

Select...

I am 18 years old or older.

Select...

I have been diagnosed with chronic pain lasting more than 3 months.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I have chronic pain because of my cancer.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ change from baseline through study completion (assessed at 3-, 6-, 9-, and 12-months follow-up)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~change from baseline through study completion (assessed at 3-, 6-, 9-, and 12-months follow-up)

This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline through study completion (assessed at 3-, 6-, 9-, and 12-months follow-up) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Chronic Pain

Opioid Misuse

Secondary study objectives

Change in Quality of Life

Depression

Generalized Anxiety

+3 more

Other study objectives

Decentering

Mindful Reappraisal of Pain Sensations

Reappraisal

+1 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Mindfulness Oriented Recovery Enhancement + Patient-centered chronic pain management visitsExperimental Treatment2 Interventions

Participants will attend a Mindfulness-Oriented Recovery Enhancement (MORE) group weekly for eight weeks, in addition to patient-centered chronic pain management visits led by their primary care provider.

Group II: Patient-centered chronic pain management visitsActive Control1 Intervention

Participants will attend patient-centered chronic pain management visits led by their primary care provider.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Mindfulness Oriented Recovery Enhancement

2020

N/A

~190

0 / 4Eligibility criteria met